Autolus Therapeutics plc (FRA:6A3A)
Germany flag Germany · Delayed Price · Currency is EUR
2.060
+0.070 (3.52%)
At close: Aug 26, 2026

Autolus Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5574516041,013308333
Market Cap Growth
40.13%-25.32%-40.39%229.38%-7.54%-12.94%
Enterprise Value
699415260956218200
Last Close Price
1.991.622.145.901.664.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.427.0361.80659.6951.70162.43
PB Ratio
8.502.971.4610.051.101.21
P/TBV Ratio
11.293.351.5110.051.101.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.956.4726.63622.4836.6997.51

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
4.921.920.702.010.500.22
Net Debt / Equity Ratio
2.220.23-0.68-0.14-0.78-0.77
Net Debt / EBITDA Ratio
-0.70-0.161.250.091.711.84
Net Debt / FCF Ratio
-0.71-0.131.270.101.891.91
Asset Turnover
0.190.110.020.000.010.01
Inventory Turnover
7.1511.11----
Quick Ratio
4.065.1310.485.908.8711.79
Current Ratio
4.895.9410.886.159.1812.15
Return on Equity (ROE)
-133.00%-94.98%-81.91%-101.61%-48.64%-54.30%
Return on Assets (ROA)
-25.44%-24.62%-26.01%-25.35%-19.94%-25.07%
Return on Capital Employed (ROCE)
-58.20%-52.40%-33.40%-53.10%-32.20%-37.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.06%-54.29%-35.28%-18.60%-45.27%-37.55%
FCF Yield
-36.61%-57.14%-36.51%-13.98%-37.45%-33.48%
Buyback Yield / Dilution
-2.10%-4.30%-46.69%-83.11%-31.78%-39.81%